Cellectar, Inc.
545 Science Drive
Madison
Wisconsin
53711
United States
Tel: 608-441-8120
Fax: 608-441-8121
Website: http://www.cellectar.com/
Email: info@cellectar.com
7 articles about Cellectar, Inc.
-
Cellectar, Inc. Announces Initiation Of Phase 2 Imaging Trial With I-124-CLR1404 In Patients With Newly Diagnosed Or Recurrent Glioblastoma
3/4/2014
-
Cellectar, Inc. Completes Enrollment in Phase I Clinical Trial of Lead Drug Candidate (131)I-CLR1404 for the Treatment of Solid Malignancies
3/9/2010
-
FDA Clears Cellectar, Inc.'s IND Application for Lead Drug Candidate
3/3/2009
-
Charles C. Harwood, Jr., Joins Cellectar, Inc.'s Board of Directors
9/18/2008
-
Cellectar, Inc. Begins GMP Production Radiopharmaceutical Production Facility to Support Clinical Development for Lead Drug Candidate and Other Molecules
8/18/2008
-
Cellectar, Inc. Raises $13 Million in Private Offering
1/8/2008
-
Cellectar LLC Expands Clinical Management Team
10/3/2007